(Approval lapsed) Dobutamine Injection USP 12.5mg/mL (250mg/20mL) - Teligent
Section 19A approved medicine
(Approval lapsed) Dobutamine Injection USP 12.5mg/mL (250mg/20mL) - Teligent
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
DBL DOBUTAMINE 250mg/20mL (as hydrochloride) injection vial - ARTG 46451
Indication(s)
Adults who require short-term treatment of cardiac failure secondary to acute myocardial infarction, or cardiac surgery.